MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ
1.085
+0.045
+4.35%
Closed 15:11 12/08 EST
OPEN
1.060
PREV CLOSE
1.040
HIGH
1.085
LOW
1.060
VOLUME
923
TURNOVER
0
52 WEEK HIGH
1.540
52 WEEK LOW
0.7500
MARKET CAP
5.91M
P/E (TTM)
-2.1320
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at XTLB last week (1127-1201)?
Weekly Report · 4d ago
Weekly Report: what happened at XTLB last week (1120-1124)?
Weekly Report · 11/27 09:36
Weekly Report: what happened at XTLB last week (1113-1117)?
Weekly Report · 11/20 09:36
Xtl Biopharmaceu: Report of foreign issuer
Press release · 11/15 17:50
Weekly Report: what happened at XTLB last week (1106-1110)?
Weekly Report · 11/13 09:34
Weekly Report: what happened at XTLB last week (1030-1103)?
Weekly Report · 11/06 09:35
Weekly Report: what happened at XTLB last week (1023-1027)?
Weekly Report · 10/30 09:40
Weekly Report: what happened at XTLB last week (1016-1020)?
Weekly Report · 10/23 09:37
More
About XTLB
XTL Biopharmaceuticals Ltd is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ: XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.